For its part, Government of India has demonstrated its commitment within the framework of World Health Organization and has started upgrading the capacity of the State Governments by equipping the State Drug Testing Laboratories with modern technology and latest rapid testing equipments. It has also considered giving price advantage to companies if they make their technology public beyond the 74 medicines notified in the DPCO that are subject to bar coding and regulatory tracing and tracking system.

The drug controller general of India, Dr G N Singh also pointed out to BioSpectrum that there is a need for a much bigger survey involving the civil society and the other agencies for finding the exact percentage of the spurious drugs. "CDSCO is working on various new initiatives and we will surely take some concrete measures in the coming months." added Dr Singh.

It is highly imperative for the authorities at helm to realize the seriousness of an issue that is a matter of life and death for patients on deathbed. Therefore sending a strong message to those who indulge in counterfeit drugs is necessary and for giving teeth to enforcement laws is a must.